360 High-Risk Vulnerability Immunization Tool V2.0 vs Halcyon Anti-Ransomware: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Halcyon Anti-Ransomware: Anti-ransomware platform protecting against attacks across the attack lifecycle. built by Halcyon. Core capabilities include AI-based ransomware detection using models trained on ransomware signals and TTPs, Behavioral engine monitoring ransomware activities across attack stages, EDR tamper detection and Last Gasp protection..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Halcyon Anti-Ransomware differentiates with AI-based ransomware detection using models trained on ransomware signals and TTPs, Behavioral engine monitoring ransomware activities across attack stages, EDR tamper detection and Last Gasp protection.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Halcyon Anti-Ransomware is developed by Halcyon. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.

360 High-Risk Vulnerability Immunization Tool V2.0 and Halcyon Anti-Ransomware serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.